JPH02330B2 - - Google Patents

Info

Publication number
JPH02330B2
JPH02330B2 JP57183643A JP18364382A JPH02330B2 JP H02330 B2 JPH02330 B2 JP H02330B2 JP 57183643 A JP57183643 A JP 57183643A JP 18364382 A JP18364382 A JP 18364382A JP H02330 B2 JPH02330 B2 JP H02330B2
Authority
JP
Japan
Prior art keywords
general formula
add
compound
water
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP57183643A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5973533A (ja
Inventor
Masakazu Yamamoto
Seiichi Araki
Hiroshi Yamamoto
Isao Yamatsu
Takeshi Suzuki
Shoji Kajiwara
Yoshikazu Suzuki
Masae Arai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Priority to JP18364382A priority Critical patent/JPS5973533A/ja
Priority to DE3348492A priority patent/DE3348492C2/de
Priority to DE3348500A priority patent/DE3348500C2/de
Priority to GB08314419A priority patent/GB2122610B/en
Priority to DE3348493A priority patent/DE3348493C2/de
Priority to DE3318989A priority patent/DE3318989C2/de
Priority to SE8303013A priority patent/SE461650B/sv
Priority to CA000429108A priority patent/CA1310660C/en
Priority to CH2902/83A priority patent/CH654823A5/fr
Priority to NL8301892A priority patent/NL194300C/nl
Priority to DK239483A priority patent/DK171640B1/da
Priority to ES522789A priority patent/ES8406992A1/es
Priority to FR838308941A priority patent/FR2527597B1/fr
Priority to IT21364/83A priority patent/IT1164256B/it
Priority to AT0197283A priority patent/AT389871B/de
Priority to FR8317173A priority patent/FR2532845B1/fr
Priority to FR8317176A priority patent/FR2532847B1/fr
Priority to FR8317169A priority patent/FR2532843A1/fr
Priority to FR8317175A priority patent/FR2532846B1/fr
Priority to FR8317170A priority patent/FR2532848B1/fr
Priority to FR8317171A priority patent/FR2532844B1/fr
Priority to ES529754A priority patent/ES8507444A1/es
Priority to ES529753A priority patent/ES8506567A1/es
Publication of JPS5973533A publication Critical patent/JPS5973533A/ja
Priority to GB08508219A priority patent/GB2159712B/en
Priority to GB08508216A priority patent/GB2159055B/en
Priority to GB08508217A priority patent/GB2159710B/en
Priority to GB08508218A priority patent/GB2159711B/en
Priority to GB08508220A priority patent/GB2159713A/en
Priority to GB08508214A priority patent/GB2159054B/en
Priority to US06/760,221 priority patent/US4624966A/en
Priority to FR858513026A priority patent/FR2569108B1/fr
Priority to SE8801515A priority patent/SE502924C2/sv
Priority to SE8801513A priority patent/SE502922C2/sv
Priority to SE8801514A priority patent/SE502923C2/sv
Publication of JPH02330B2 publication Critical patent/JPH02330B2/ja
Priority to US08/011,197 priority patent/US5280048A/en
Priority to US08/584,145 priority patent/US6111131A/en
Priority to US08/601,489 priority patent/US6288128B1/en
Priority to US08/599,944 priority patent/US5658958A/en
Priority to NL9900009A priority patent/NL9900009A/nl
Granted legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP18364382A 1982-05-28 1982-10-21 β，γ−ジヒドロポリプレニルアルコ−ル誘導体 Granted JPS5973533A (ja)

Priority Applications (39)

Application Number Priority Date Filing Date Title
JP18364382A JPS5973533A (ja) 1982-10-21 1982-10-21 β，γ−ジヒドロポリプレニルアルコ−ル誘導体
DE3348492A DE3348492C2 (de) 1982-05-28 1983-05-25 Verwendung eines ß,gamma-Dihydropolyprenylalkoholderivats zur Prophylaxe und Therapie von durch Immunmangelerscheinungen verursachten Infektionskrankheiten
DE3348500A DE3348500C2 (de) 1982-05-28 1983-05-25 beta,gamma-Dihydropolyprenylalkoholderivat
GB08314419A GB2122610B (en) 1982-05-28 1983-05-25 A polyprenyl compound and a pharmaceutical composition containing a polyprenyl compound
DE3348493A DE3348493C2 (de) 1982-05-28 1983-05-25 Verwendung von Docosanol zur Behandlung und Prophylaxe von durch Immunmangelerscheinungen verursachten Infektionskrankheiten
DE3318989A DE3318989C2 (de) 1982-05-28 1983-05-25 ß,gamma-Dihydropolyprenylalkoholderivate und diese enthaltende Arzneimittel und deren Verwendung
SE8303013A SE461650B (sv) 1982-05-28 1983-05-27 B -dihydropolyprenylalkoholderivat och farmaceutisk komposition innehaallande detsamma
CA000429108A CA1310660C (en) 1982-05-28 1983-05-27 B, -dihydropolyprenyl alcohol derivatives and pharmaceutical composition containing a polyprenyl compound
CH2902/83A CH654823A5 (fr) 1982-05-28 1983-05-27 Derives de l'alcool beta, gamma-dihydropolyprenylique et compositions pharmaceutiques contenant un compose polyprenylique.
NL8301892A NL194300C (nl) 1982-05-28 1983-05-27 Farmaceutisch preparaat, dat een polyprenol als werkzaam bestanddeel bevat, alsmede voor toepassing daarin geschikte polyprenolen.
DK239483A DK171640B1 (da) 1982-05-28 1983-05-27 Analogifremgangsmåde til fremstilling af beta, gamma-dihydro-polyprenylalkoholderivater
ES522789A ES8406992A1 (es) 1982-05-28 1983-05-27 Un derivado de un alcohol b,v-dihidropoliprenilico.
FR838308941A FR2527597B1 (fr) 1982-05-28 1983-05-30 Derives d'alcool b,g-dihydropolyprenylique et composition pharmaceutique contenant un compose polyprenylique
IT21364/83A IT1164256B (it) 1982-05-28 1983-05-30 Derivati di beta, alfa-diidropoliprenil alcool e composizione farmaceutica contenente un composto di poliprenile
AT0197283A AT389871B (de) 1982-05-28 1983-05-30 Verfahren zur herstellung von beta, gamma -dihydropolyprenylalkoholderivaten
FR8317170A FR2532848B1 (fr) 1982-05-28 1983-10-27 Composition pharmaceutique contenant un derive polyprenylique
FR8317176A FR2532847B1 (fr) 1982-05-28 1983-10-27 Composition pharmaceutique comprenant a titre de principe actif le 3,7,11,15-tetramethylhexadeca-1-ene-3-ol
FR8317169A FR2532843A1 (fr) 1982-05-28 1983-10-27 Composition pharmaceutique comprenant a titre de principe actif le phytol ou l'isophytol
FR8317175A FR2532846B1 (fr) 1982-05-28 1983-10-27 Composition pharmaceutique comprenant a titre de principe actif le 3,7,11,15 - tetramethyl -1,6,10,14-hexadecatetraene-3-ol
FR8317173A FR2532845B1 (fr) 1982-05-28 1983-10-27 Composition pharmaceutique comprenant a titre de principe actif le docosanol
FR8317171A FR2532844B1 (fr) 1982-05-28 1983-10-27 Composition pharmaceutique contenant un compose polyprenylique
ES529754A ES8507444A1 (es) 1982-05-28 1984-02-15 Un procedimiento para la preparacion de un derivado de un alcohol , -dihidropoliprenilico
ES529753A ES8506567A1 (es) 1982-05-28 1984-02-15 Un procedimiento para la preparacion de un derivado de un alcohol , -dihidropoliprenilico
GB08508214A GB2159054B (en) 1982-05-28 1985-03-29 Pharmaceutical compositions of polyprenyl alcohols
GB08508220A GB2159713A (en) 1982-05-28 1985-03-29 Containing a polyprenyl compound
GB08508216A GB2159055B (en) 1982-05-28 1985-03-29 Pharmaceutical compositions of 3,7,11,15-tetra-methylhexadec-1-en-3-ol
GB08508217A GB2159710B (en) 1982-05-28 1985-03-29 Containing a polyprenyl compound
GB08508218A GB2159711B (en) 1982-05-28 1985-03-29 Containing a polyprenyl compound
GB08508219A GB2159712B (en) 1982-05-28 1985-03-29 Containing a polyprenyl compound
US06/760,221 US4624966A (en) 1982-05-28 1985-07-29 β,γ-dihydropolyprenyl alcohol derivatives and pharmaceutical composition containing a polyprenyl compound
FR858513026A FR2569108B1 (fr) 1982-05-28 1985-09-02 Composition pharmaceutique contenant un compose polyprenylique
SE8801514A SE502923C2 (sv) 1982-05-28 1988-04-22 Användning av en polyprenylförening för framställning av protylaktiskt/terapeutiskt medel för humana och animala sjukdomar beroende på bristfälligt immunförsvar
SE8801513A SE502922C2 (sv) 1982-05-28 1988-04-22 Användning av en polyprenylförening för framställning av profylaktiskt/terapeutiskt medel för humana och animala sjukdomar beroende på bristfälligt immunförsvar
SE8801515A SE502924C2 (sv) 1982-05-28 1988-04-22 Farmaceutisk komposition innehållande en verksam mängd av 3,7,11,15-tetrametyl-hexadeka-1-en-3-ol eller 3,7,11,15- tetrametyl-1,6,10,14-hexadekatetraen-3-ol
US08/011,197 US5280048A (en) 1982-05-28 1993-01-29 β,γ-dihydropolyprenyl alcohol derivatives and pharmaceutical composition containing a polyprenyl compound
US08/584,145 US6111131A (en) 1982-05-28 1996-01-11 Beta, gamma-dihydropolyprenyl alcohol derivatives and pharmaceutical composition containing a polyprenyl compound
US08/601,489 US6288128B1 (en) 1982-05-28 1996-02-14 β,γ-dihydropolyprenyl alcohol derivatives and pharmaceutical composition containing a polyprenyl compound
US08/599,944 US5658958A (en) 1982-05-28 1996-02-14 β, γ-dihydropolyprenyl alcohol derivatives effective at mitigating stress in animals
NL9900009A NL9900009A (nl) 1982-05-28 2000-12-05 Beta, gamma-dihydropolyprenylalcoholderivaten en farmaceutisch preparaat, dat een polyprenylverbinding bevat.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP18364382A JPS5973533A (ja) 1982-10-21 1982-10-21 β，γ−ジヒドロポリプレニルアルコ−ル誘導体

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP14549089A Division JPH0228108A (ja) 1989-06-09 1989-06-09 免疫機能不全による疾患の予防・治療剤

Publications (2)

Publication Number Publication Date
JPS5973533A JPS5973533A (ja) 1984-04-25
JPH02330B2 true JPH02330B2 (enrdf_load_stackoverflow) 1990-01-08

Family

ID=16139374

Family Applications (1)

Application Number Title Priority Date Filing Date
JP18364382A Granted JPS5973533A (ja) 1982-05-28 1982-10-21 β，γ−ジヒドロポリプレニルアルコ−ル誘導体

Country Status (1)

Country Link
JP (1) JPS5973533A (enrdf_load_stackoverflow)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5714645A (en) * 1995-10-31 1998-02-03 Kuraray Co., Ltd. Process for producing all trans-form polyprenols

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58206517A (ja) * 1982-05-28 1983-12-01 Eisai Co Ltd 免疫機能不全による疾患の予防・治療剤

Also Published As

Publication number Publication date
JPS5973533A (ja) 1984-04-25

Similar Documents

Publication Publication Date Title
US3816393A (en) Clathrate compounds of prostaglandins or their analogues with cyclo-dextrin
US6288128B1 (en) β,γ-dihydropolyprenyl alcohol derivatives and pharmaceutical composition containing a polyprenyl compound
US4054736A (en) Clathrate compounds of prostaglandins or their analogues with cyclodextrin
GB1602566A (en) Therapeutic preparations for peptic ulcers comprising aliphatic ketone derivatives
JPH02330B2 (enrdf_load_stackoverflow)
US5280048A (en) β,γ-dihydropolyprenyl alcohol derivatives and pharmaceutical composition containing a polyprenyl compound
JPH0349891B2 (enrdf_load_stackoverflow)
US5658958A (en) β, γ-dihydropolyprenyl alcohol derivatives effective at mitigating stress in animals
JPS6320426B2 (enrdf_load_stackoverflow)
JPH026326B2 (enrdf_load_stackoverflow)
JPS6039257B2 (ja) 新規な潰瘍治療活性酢酸誘導体
US3266986A (en) Hypnotic composition containing reaction product of chloral hydrate and acetylglycineamide
JPS5936615A (ja) 発がん予防剤
JPS58225039A (ja) ポリプレニル系化合物
JPS6126795B2 (enrdf_load_stackoverflow)
JPS6032763A (ja) 新規な１１−オキソプロスタン酸誘導体ならびにその利用
JPH026328B2 (enrdf_load_stackoverflow)
NL9900009A (nl) Beta, gamma-dihydropolyprenylalcoholderivaten en farmaceutisch preparaat, dat een polyprenylverbinding bevat.
JPS6160060B2 (enrdf_load_stackoverflow)
JPH06157306A (ja) ペニシライド系化合物を有効成分とする脂質低下剤
GB2159709A (en) Pharmaceutical compositions of polyprenyl ketones
JPH0228575B2 (ja) Kokanenzai
JPS6113445B2 (enrdf_load_stackoverflow)
JPS6126796B2 (enrdf_load_stackoverflow)
EP0025880A1 (en) Azetidine derivative, its production, the derivative for use as an anti-obesity agent